about
Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatmentMDM2 and MDMX: Alone and together in regulation of p53Externally modulated theranostic nanoparticlesIntegrative clustering methods for high-dimensional molecular data.A recursively partitioned mixture model for clustering time-course gene expression dataTaming immune suppressor: application of myeloid-derived suppressor cells in anti-cancer gene therapy.Defining functional changes in the brain caused by targeted stereotaxic radiosurgery.Helicobacter pylori vacuolating cytotoxin and gastric cancer risk: reconsidered.Coexpression and expression quantitative trait loci analyses of the angiogenesis gene-gene interaction network in prostate cancer.Harnessing protein kinase A activation to induce mesenchymal-epithelial programs to eliminate chemoresistant, tumor-initiating breast cancer cellsA crowded, but still varied, space: brigatinib in anaplastic lymphoma kinase-rearranged non-small cell lung cancer.Statistical strategies for microRNAseq batch effect reductionConvergence of nanotechnology with radiation therapy-insights and implications for clinical translation.DNA ligases as therapeutic targetsPathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implicationsGold nanoparticles in radiation research: potential applications for imaging and radiosensitization.Improving chemoradiotherapy with nanoparticle therapeutics.New developments in treatment planning and verification of particle beam therapy.Computational methods and opportunities for phosphorylation network medicineMolecular mechanisms involved in tumor repopulation after radiotherapy.Frameless single-isocenter intensity modulated stereotactic radiosurgery for simultaneous treatment of multiple intracranial metastases.The promise and challenge of ovarian cancer models.An improved understanding of cancer genomics through massively parallel sequencing.Cancer biomarker discovery and validation.Normal tissue protection for improving radiotherapy: Where are the Gaps?The STAMPEDE trial: paradigm-changing data through innovative trial design.Oncolytic virus-mediated tumor radiosensitization in mice through DNA-PKcs-specific shRNA.A chain reaction approach to modelling gene pathwaysSensitization of tumor cells to cancer therapy by molecularly targeted inhibition of the inhibitor of nuclear factor κB kinase.Into the eye of the storm: breast cancer's somatic mutation landscape points to DNA damage and repairIdentification of cancer mechanisms through computational systems modeling.Sparse principal component analysis in cancer research.Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat's in the fireDNA crosslinking damage and cancer - a tale of friend and foe.DNA double strand break repair via non-homologous end-joining.Precision Oncology: Identifying Predictive Biomarkers for the Treatment of Metastatic Renal Cell CarcinomaDNA damage tolerance: a double-edged sword guarding the genomeActionable Intelligence Provided by Pancreatic Cancer Genomic Landscape: Are Targets for Curative Therapy On The Map?Positron emission tomography/computerized tomography for tumor response assessment-a review of clinical practices and radiomics studiesHematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury.
P1433
Q28274124-7FF401CD-1B69-4C71-A044-8B42CD78CA1CQ28611422-F7E1E2A9-0128-46B2-8996-7C5BDCDD82BEQ30438597-86DA1443-2053-4670-8378-827BB489E425Q30854282-905BAF37-FC83-41B3-9061-2AEF277545A4Q30864080-2C35B76C-CB3D-4403-B9DD-B121AC7BA71BQ33664499-7A1126FA-2C18-4547-AEFB-224F304D591FQ33705495-05DD191D-6A97-4E85-81A2-03F0713FF882Q33829091-0DA411ED-0A95-4EB7-A2D9-EA90440C1672Q33838280-36B5B277-DE18-4692-A547-0C8DE57F56A1Q33865464-1EAC8942-28F4-429E-B21A-42D50DC405A3Q33865475-6EB61A42-D7CC-4AA9-B161-0593A7325BC8Q34229284-D258D60D-BCE3-4E15-B2AE-A0EE7D3EC3D3Q34263669-6E077A90-8102-40A7-825A-D124DC3AF18FQ34384677-B457C07C-DEC7-4A3D-8385-EA149F483184Q34501822-43B21900-D059-4694-A450-C47DC341C7FAQ34563668-62DFFE2F-A864-4D50-BFD1-0056DD9A7014Q34564219-59836B8E-D55A-4486-8625-9D545EEB537AQ34700374-813C0867-AF52-4EAD-A606-6A0E0A64985DQ34742859-A28F9DBA-D8A7-4F3B-85E5-B16BACD0D246Q34948795-E1442E19-0AB9-4076-972C-185B1CF9F2C0Q35218917-C6C77388-2051-4602-AA73-99CA82A5E5DFQ35771750-EE7E1D6D-C3DE-404C-99B8-233B98A6CF23Q35801066-41BB36AE-B6D4-40F3-9FFE-9A2211C0335BQ35879887-1D649719-F55D-4FB5-8EE3-BEF1F3C1EF6BQ36137870-622615A5-5B97-455C-BCF8-8F6F10C6FA56Q36163344-7E59BC6B-49F0-4A7D-90D8-847EC80F348BQ36186664-49FBC6FF-3626-4E07-9AA7-AAED8062879CQ36199800-B9CA2518-6808-4A43-8A41-1D674FDB6C88Q36204370-D2D9B6E3-206F-42BF-BBA4-195B2115AADAQ36311747-9CED6F47-87F1-48E3-ABC5-5FC9675C3E61Q36357667-3B0BF0FD-A7CE-416B-840D-6B3243D4EE67Q36407448-A4141378-8673-47BE-A0AA-E23B12038AB0Q36708344-76E3006B-DA08-4A1C-BFB9-BDBD55F61680Q37127343-8348C7E0-C101-41D9-B3AB-1FEB1AB5FB0AQ37135926-9E9C9EEF-35A4-4707-93E2-2AB1FDD57F04Q37179808-637DCB7B-2733-498E-AD6C-1EDEB27328B3Q37187991-F707D3C4-4C9D-4B5D-8FD7-094B2F62676FQ37265792-8859CA93-BA1C-4EF6-AB2F-996A10E0F6D4Q37444081-DE70C6C9-F73C-488F-ACAC-6E4B10B67A5DQ37616321-63CB0505-BC1C-4C4D-BE19-E8B0AD1BC19C
P1433
description
journal
@en
revista científica
@es
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Translational cancer research
@ast
Translational cancer research
@en
Translational cancer research
@es
Translational cancer research
@nl
type
label
Translational cancer research
@ast
Translational cancer research
@en
Translational cancer research
@es
Translational cancer research
@nl
altLabel
Transl Cancer Res
@en
prefLabel
Translational cancer research
@ast
Translational cancer research
@en
Translational cancer research
@es
Translational cancer research
@nl
P4616
P1055
P1156
21100455430
P1476
Translational cancer research
@en